A possible association between cervical erosion in pregnant women and congenital abnormalities in their children-a population-based case-control study
Ferenc Bánhidy, Nándor Ács, Erzsébet H. Puhó, Andrew E. Czeizel
.
DOI: 10.4236/health.2010.28140   PDF    HTML     4,629 Downloads   9,258 Views   Citations

Abstract

Objective to study the possible association between erosion of cervix in pregnant women (ECP) and structural birth defects, i.e. congenital abnormalities (CA) in their offspring. Study design: Comparison of cases with CA and all matched controls without any CA born to wo- men with prospectively and medical record ECP in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). Results: HCC- SCA contained 22,843 cases and 38,151 matched controls, the informative offspring of 40 (0.18%) case mothers and the newborns of 25 control mothers (0.07%) with ECP were compared and the higher risk for total CA (adjusted OR with 95% CI: 2.7, 1.6-4.4) was found explained by the higher risk of 9 cases with hypospadias (OR with 95% CI: 4.5, 2.1-9.7) and 10 cases with car-diovascular CAs (OR with 95% CI: 3.4, 1.6-7.1), particularly with conotruncal CAs. Conclusions: An unexpected possible association of ECP with higher risk for hypospadias and conotrun-cal cardiovascular CAs was found and these findings are considered as signals that need confirmation or rejection

Share and Cite:

Bánhidy, F. , Ács, N. , Puhó, E. and Czeizel, A. (2010) A possible association between cervical erosion in pregnant women and congenital abnormalities in their children-a population-based case-control study. Health, 2, 945-950. doi: 10.4236/health.2010.28140.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Czeizel, A.E., ács, N., Bánhidy, F. and Vogt, G. (2006) Possible association between maternal diseases during pregnancy and congenital abnormalities. In: Engels, J.V., Ed. Birth defects: New research. NOVA Science Pub-lisher, New York, 55-70.
[2] Gabbe, S.G., Niebyl, J.R. and Simpson, J.L. (2001) Ob-stetrics: Normal and problem pregnancies. 4th Edition, Churchill Livingstone, New York.
[3] Shepard, T.H. and Lemire, R.J. (2004) Catalog of Tera-togenic Agents, 11th Edition. Johns Hopkins University Press, Baltimore.
[4] Czeizel, A.E., Rockenbauer, M., Siffel, C. and Varga, E. (2001) Description and mission evaluation of the hun-garian case-control surveillance of congenital abnormali-ties, 1980-1996. Teratology, 63(5), 176-185.
[5] Czeizel, A.E. (1997) First 25 years of the hungarian con-genital abnormality registry. Teratology, 55(5), 299-305.
[6] Czeizel, A.E., Petik, D. and Vargha, P. (2003) Validation studies of drug exposures in pregnant women. Pharma-coepid Drug Safety, 12(5), 409-416.
[7] Czeizel, A.E. and Vargha, P. (2004) Periconceptional folic acid/multivitamin supplementation and twin pre- gnancy. American Journal of Obstetrics and Gynecology, 191(3), 790-794.
[8] WHO. (2007) International classification of disease. 10th revision, Wold Health Organization, Geneva.
[9] Puho, E., Métneki, J. and Czeizel, A.E. (2005) Maternal employment status and isolated orofacial clefts in Hungary. Central European Journal of Public Health, 13(3), 144-148.
[10] Adams, F.H., Emmanouilideas, G.C. and Riemenschnei-der, T.A. (1989) Heart disease in infants, children and adolescents. Williams and Wilkins, Baltimore.
[11] ács, F., Bánhidy, F., Puho, H.E. and Czeizel, A.E. (2008) Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring? A population-based case-control study. Birth Defects Research (Part A), 82(8), 563-570.
[12] Sharpe, R.M. and Skakkeback, N.E. (1993) Are oestro-gens involved in falling sperm counts and disorders of the male reproductive tract? Lancet, 341(8857), 1392- 1395.
[13] Kim, K.S., Torres, C.R. Jr, Yucel, S., et al. (2004) Induc-tion of hypospadis in a murine model by maternal expo-sure to synthetic estrogens. Environmental Research, 94, 267-275.
[14] Janerich, D.T., Dugan, J.M., Standfast, S.J. and Strite, L. (1977) Congenital heart disease and prenatal exposure to exogenous sex hormeones. British Medical Journal, 1(6068), 1058-1060.
[15] Bracken, M.B. (1990) Oral contraception and congenital malformations in offspring: A review and meta-analysis of the prospective studies. Obstetrics & Gynecology, 76(3), 552-557.
[16] Czeizel, A.E. (2009) The estimation of human terato-genic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology. Expert Opinion on Drug Safety, 8(3), 283-303.
[17] Czeizel, A.E., Er?s, E., Rockenbauer, M., S?rensen, H.T. and Olsen, J. (2003) Shortterm oral diazepam treatment during pregnancy—A population-based teratological case-control study. Clinical Drug Investigation, 23, 451- 462.
[18] Bártfai, Z., Kocsis, J., Puhó, H.E. and Czeizel, A.E. (2008) A population-based case-control study of pro- methazine use during pregnancy. Reproductive Toxicol-ogy, 25(2), 276-285.
[19] Gidai, J., ács, N., Bánhidy, F. and Czeizel, A.E. (2008) No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Toxic In-dust Health, 24, 29-39.
[20] Petik, D., ács, N., Bánhidy, F. and Czeizel, A.E. (2008) A study of the potential teratogenic effects of large doses of promethazine in 32 self-poisoned pregnant women. Toxic Indust Health, 24(1-2), 87-96.
[21] Czeizel, A.E. and Huiskes, N. (1988) A case-control study to evaluate the risk of congenital anomalies as a result of allylestrenol therapy during pregnancy. Clinical Therapeutics, 10, 725-739.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.